A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer

Overview of attention for article published in BMC Cancer, May 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 116 Dimensions

Readers on

mendeley: 113 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Win or loss? Combination therapy does improve the oncolytic virus therapy to pancreatic cancer

Cancer Cell International, 20 Apr 2022

Abstract Pancreatic cancer (PC) is a growing global burden, remaining one of the most lethal cancers of the gastrointestinal…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.